Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA. 

Life Sciences

Mirador Therapeutics

Mark McKenna

Olivier Laurent

Nori Ebersole

Brian Russell

Chris Schaumburg

Tim Andrews

Maulik S.

Vika Brough

Jordan Zwick

The Leadership Team at Mirador Therapeutics is responsible for setting the strategic direction and vision of the company, ensuring alignment with its mission to advance precision medicines for immune-mediated inflammatory and fibrotic diseases. This team oversees critical functions including scientific research, legal affairs, financial management, executive leadership, medical strategy, human resources, business development, and strategic planning to drive the company's growth and success.

Leadership Team

The Research and Development team at Mirador Therapeutics focuses on discovering and advancing new precision medicines for chronic immune-mediated inflammatory and fibrotic diseases. Leveraging Mirador360™ and the latest in human genetics and data science, the team, led by prominent experts such as the Chief Scientific Officer, Richard Graham, Ph.D., and William Sandborn, M.D., drives innovation from early-stage research through clinical development.

Research and Development

Mirador Therapeutics

Org chart

Teams

Leadership Team

Research and Development

Offices

Mirador Therapeutics

Org chart

Teams

Leadership Team

Research and Development

Offices

Related companies